JUNIPER PHARMACEUTICALS INC: 10-Q filed 2012-08-08
What JUNIPER PHARMACEUTICALS INC reported in its quarterly report filed 2012-08-08 (fiscal Q2 2012): 41 published measures, 119 facts as tagged in accession 0000821995-12-000046.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-08-08
- Fiscal period
- fiscal Q2 2012
- Accession
- 0000821995-12-000046 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All JUNIPER PHARMACEUTICALS INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 35,116,060 | USD | |
| At 2011-12-31 | 36,082,586 | USD | |
| At 2011-06-30 | 35,647,235 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 6,422,623 | USD | |
| At 2011-12-31 | 14,851,779 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 28,093,437 | USD | |
| At 2011-12-31 | 20,630,807 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 7,716,818 | USD | |
| At 2011-12-31 | 10,114,163 | USD | |
| At 2011-06-30 | 21,760,780 | USD | |
| At 2010-12-31 | 21,630,979 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 1,942,810 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 6,897,203 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 18,314,195 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 17,127,308 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -1,343,669 | USD | 182 |
| 2011-01-01 to 2011-06-30 | -5,523,268 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 1,044,871 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 625,344 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -15,000 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 3,154,869 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -1,044,871 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 2,474,656 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | -251,385,550 | USD | |
| At 2011-12-31 | -258,282,753 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 87,305,184 | shares | 91 |
| 2012-01-01 to 2012-06-30 | 87,300,585 | shares | 182 |
| 2011-04-01 to 2011-06-30 | 86,982,750 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 85,352,044 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 87,344,009 | shares | 91 |
| 2012-01-01 to 2012-06-30 | 87,300,585 | shares | 182 |
| 2011-04-01 to 2011-06-30 | 95,851,956 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 89,534,165 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 0.02 | USD/shares | 91 |
| 2012-01-01 to 2012-06-30 | 0.08 | USD/shares | 182 |
| 2011-04-01 to 2011-06-30 | 0.21 | USD/shares | 91 |
| 2011-01-01 to 2011-06-30 | 0.2 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 0.02 | USD/shares | 91 |
| 2012-01-01 to 2012-06-30 | 0 | USD/shares | 182 |
| 2011-04-01 to 2011-06-30 | 0.16 | USD/shares | 91 |
| 2011-01-01 to 2011-06-30 | 0.19 | USD/shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 0 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 2,676 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 1,576 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 4,504 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 2,205,822 | USD | |
| At 2011-12-31 | 1,481,071 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 487,981 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 504,383 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 1,682,262 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 407,814 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 15,737,056 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 22,436,636 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 32,871,363 | USD | |
| At 2011-12-31 | 34,137,229 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 0 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 0 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 3,888 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 7,776 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 4,678,955 | USD | |
| At 2011-12-31 | 6,636,517 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 2,182,460 | USD | |
| At 2011-12-31 | 3,526,171 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 4,483,910 | USD | |
| At 2011-12-31 | 4,695,410 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 0 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 125,381 | USD | 181 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 2,082,428 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 5,187,431 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 504,975 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 4,264,896 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 4,438,658 | USD | |
| At 2011-12-31 | 3,635,730 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 3,764,690 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 5,595,245 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 16,242,031 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 26,701,532 | USD | 181 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 4,465,846 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 6,468,832 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 3,002,088 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 5,036,926 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 159,072 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 712,750 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 507,949 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 1,853,550 | USD | 181 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 278,531,355 | USD | |
| At 2011-12-31 | 278,060,138 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 197,348 | USD | |
| At 2011-12-31 | 104,902 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 2,465,245 | USD | |
| At 2011-12-31 | 3,016,596 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 990,016 | USD | |
| At 2011-12-31 | 667,927 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 1,925,825 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 6,989,649 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 18,318,184 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 17,132,538 | USD | 181 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 1,935,310 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 6,882,203 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 18,306,695 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 17,112,308 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 1,923,356 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 4,474,681 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 2,500,326 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 4,856,804 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -8,776 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -95,747 | USD | 182 |
| 2011-04-01 to 2011-06-30 | -218,327 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -320,187 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 260,548 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 6,492,065 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 2,578,715 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -5,304,824 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -211,500 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 4,941,991 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 1,364,566 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 483,645 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -1,343,711 | USD | 182 |
| 2011-01-01 to 2011-06-30 | -2,093,664 | USD | 181 |
Inspect the source
- Entity
- JUNIPER PHARMACEUTICALS INC / CIK 0000821995
- Captured
- SEC response SHA-256
a3edd41c17929d04dd1a474f6ef2c35d05b3649e973c4fa27e448166db6cfbcf
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000821995.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))